The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Cai, Wen ^a   Kramarova, Tatiana V ^a   Berg, Petra ^a   Korbonits, Marta ^b   Pongratz, Ingemar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; IMMUNOPHILIN; UNCLASSIFIED DRUG; X PROTEIN ASSOCIATED PROTEIN 2; ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; ARYL HYDROCARBON RECEPTOR-INTERACTING PROTEIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA, HUMAN; ISOPROTEIN; REPRESSOR PROTEIN; SIGNAL PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GROWTH REGULATION BY ESTROGEN IN BREAST CANCER 1 GENE; HUMAN; HUMAN CELL; MARKER GENE; MUTATION; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; PS2 GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGICAL MODEL; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; INTRACELLULAR SPACE; METABOLISM; MOUSE; PROTEIN BINDING; TUMOR CELL LINE;

HEPATITIS B VIRUS;

ANIMALS; CELL LINE, TUMOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SPACE; MICE; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN ISOFORMS; REPRESSOR PROTEINS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 80053446776     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025201     Document Type: Article

References (44)

1. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH, (1998) Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol 18: 978-988.
2. Carver LA, Bradfield CA, (1997) Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 272: 11452-11456.
3. Ma Q, Whitlock JP, (1997) A novel cytoplasmic protein that interacts with the Ah receptor, contains tetratricopeptide repeat motifs, and augments the transcriptional response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Biol Chem 272: 8878-8884.
4. Carver LA, LaPres JJ, Jain S, Dunham EE, Bradfield CA, (1998) Characterization of the Ah receptor-associated protein, ARA9. J Biol Chem 273: 33580-33587.
5. Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto E, (1996) XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 24: 4741-4750.
6. Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, et al. (2008) The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab 93: 2390-2401.
7. Berg P, Pongratz I, (2002) Two parallel pathways mediate cytoplasmic localization of the dioxin (aryl hydrocarbon) receptor. J Biol Chem 277: 32310-32319.
8. Meyer BK, Perdew GH, (1999) Characterization of the AhR-hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 38: 8907-8917.
9. Kazlauskas A, Poellinger L, Pongratz I, (2000) The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J Biol Chem 275: 41317-41324.
10. Swedenborg E, Pongratz I, (2010) AhR and ARNT modulate ER signaling. Toxicology 268: 132-138.
11. Nakata A, Urano D, Fujii-Kuriyama Y, Mizuno N, Tago K, et al. (2009) G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor. EMBO Rep 10: 622-628.
12. Laenger A, Lang-Rollin I, Kozany C, Zschocke J, Zimmermann N, et al. (2009) XAP2 inhibits glucocorticoid receptor activity in mammalian cells. FEBS Lett 583: 1493-1498.
13. Froidevaux MS, Berg P, Seugnet I, Decherf S, Becker N, et al. (2006) The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo. EMBO Rep 7: 1035-1039.
14. Sumanasekera WK, Tien ES, Turpey R, Vanden Heuvel JP, Perdew GH, (2003) Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2. J Biol Chem 278: 4467-4473.
15. Swedenborg E, Ruegg J, Hillenweck A, Rehnmark S, Faulds MH, et al. (2008) 3-Methylcholanthrene displays dual effects on estrogen receptor (ER) alpha and ER beta signaling in a cell-type specific fashion. Mol Pharmacol 73: 575-586.
16. Pratt WB, Toft DO, (1997) Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 18: 306-360.
17. Swedenborg E, Ruegg J, Makela S, Pongratz I, (2009) Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J Mol Endocrinol 43: 1-10.
18. Meltser I, Tahera Y, Simpson E, Hultcrantz M, Charitidi K, et al. (2008) Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest 118: 1563-1570.
19. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P, (2004) Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11: 537-551.
20. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, et al. (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87: 905-931.
21. Feigelson HS, Henderson BE, (1996) Estrogens and breast cancer. Carcinogenesis 17: 2279-2284.
22. Persson I, Weiderpass E, Bergkvist L, Bergstrom R, Schairer C, (1999) Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control 10: 253-260.
23. Greiser CM, Greiser EM, Doren M, (2007) Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update 13: 453-463.
24. Heaney AP, (2007) Targeting pituitary tumors. Horm Res 68 (Suppl 5): 132-136.
25. Zeng Q, Chen G, Vlantis A, Tse G, van Hasselt C, (2008) The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. J Pathol 214: 425-433.
26. Pravettoni A, Mornati O, Martini PG, Marino M, Colciago A, et al. (2007) Estrogen receptor beta (ERbeta) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Mol Cell Endocrinol 263: 46-54.
27. Hartman J, Edvardsson K, Lindberg K, Zhao C, Williams C, et al. (2009) Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells. Cancer Res 69: 6100-6106.
28. Trivellin G, Korbonits M, (2011) AIP and its interacting partners. J Endocrinol 210: 137-155.
29. Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, et al. (2010) Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat 31: 950-960.
30. Fujimoto M, Yoshino E, Hirakawa K, Chihara K, Ibata Y, (1987) Studies on estrogen induced pituitary tumor in the rat with special reference to the relationship of the tuberoinfundibular dopamine neuron system. J Neurooncol 5: 151-159.
31. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S, (1999) Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 5: 1317-1321.
32. Naves LA, Daly AF, Vanbellinghen JF, Casulari LA, Spilioti C, et al. (2007) Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. Eur J Endocrinol 157: 383-391.
33. Brunnberg S, Pettersson K, Rydin E, Matthews J, Hanberg A, et al. (2003) The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription. Proc Natl Acad Sci U S A 100: 6517-6522.
34. Ruegg J, Swedenborg E, Wahlstrom D, Escande A, Balaguer P, et al. (2008) The transcription factor aryl hydrocarbon receptor nuclear translocator functions as an estrogen receptor beta-selective coactivator, and its recruitment to alternative pathways mediates antiestrogenic effects of dioxin. Mol Endocrinol 22: 304-316.
35. Levenson AS, Jordan VC, (1997) MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res 57: 3071-3078.
36. Faulds MH, Olsen H, Helguero LA, Gustafsson JA, Haldosen LA, (2004) Estrogen receptor functional activity changes during differentiation of mammary epithelial cells. Mol Endocrinol 18: 412-421.
37. Cai W, Rambaud J, Teboul M, Masse I, Benoit G, et al. (2008) Expression levels of estrogen receptor beta are modulated by components of the molecular clock. Mol Cell Biol 28: 784-793.
38. Ghosh MG, Thompson DA, Weigel RJ, (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60: 6367-6375.
39. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, et al. (2000) Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 43: 4934-4947.
40. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, et al. (2001) Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 4230-4251.
41. Goebl M, Yanagida M, (1991) The TPR snap helix: a novel protein repeat motif from mitosis to transcription. Trends Biochem Sci 16: 173-177.
42. Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M, (2010) Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab 21: 419-427.
43. Lin BC, Sullivan R, Lee Y, Moran S, Glover E, et al. (2007) Deletion of the aryl hydrocarbon receptor-associated protein 9 leads to cardiac malformation and embryonic lethality. J Biol Chem 282: 35924-35932.
44. Kang BH, Xia F, Pop R, Dohi T, Socolovsky M, et al. (2011) Developmental Control of Apoptosis by the Immunophilin Aryl Hydrocarbon Receptor-interacting Protein (AIP) Involves Mitochondrial Import of the Survivin Protein. J Biol Chem 286: 16758-16767.